INTL FLAVORS & FRAGRANCES (IFF)       114.105  +0.59 (+0.52%)

114.105  +0.59 (+0.52%)

US4595061015 - Common Stock


Fundamental Rating

2

Taking everything into account, IFF scores 2 out of 10 in our fundamental rating. IFF was compared to 122 industry peers in the Chemicals industry. Both the profitability and financial health of IFF have multiple concerns. While showing a medium growth rate, IFF is valued expensive at the moment.

Note: IFF has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

IFF has a Piotroski-F score of 4.00. This indicates an average health and profitability for IFF.

VS Industry

Valuation

Valuation Rating

1

When comparing the price book ratio of IFF to the average industry price book ratio of 2.20, IFF is valued rather cheaply.
The Price/Earnings Ratio is 20.05, which indicates a rather expensive current valuation of IFF.
With a Forward Price/Earnings Ratio of 19.39, IFF is valued rather expensively.
With a price book ratio of 1.72, IFF is valued correctly.

Compared to an average industry Price/Earning Ratio of 13.22, IFF is valued slightly more expensive.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
Compared to an average industry Enterprise Value to EBITDA ratio of 9.24, IFF is valued more expensive than its industry peers. 83% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (20.05) VS Industry: 26% outperformed.

606.52
1.93

Price/Book (1.72) VS Industry: 65% outperformed.

764.36
0.03

Enterprise Value/ EBITDA (16.84) VS Industry: 17% outperformed.

13,692.96
1.59

Growth

Growth Rating

5

When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
Looking at the last year, IFF shows a very strong growth in Revenue. The Revenue has grown by 27.61%.
The Revenue has been growing by 30.19% on average over the past 5 years. This is a very strong growth!
IFF shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.40%.

Measured over the past 5 years, IFF shows a small growth in Earnings Per Share. The EPS has been growing by 0.61% on average per year.
Based on estimates for the next 5 years, IFF will show a small growth in Earnings Per Share. The EPS will grow by 8.19% on average per year.
IFF is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 4.79% yearly.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS0.61% -2.99% -3.4% -0.52% 1.87% 5.42% 8.19%
Revenue30.19% 43.1% 27.61% 7.72% 4.34% 4.44% 4.79%

Health

Health Rating

2

IFF has a Current Ratio of 1.79. This is a normal value and indicates that IFF is financially healthy and should not expect problems in meeting its short term obligations.
The Debt to Equity ratio of IFF is in line with the industry averages.
The Piotroski-F score of IFF is 4.00. This is a neutral score and indicates average health and profitability for IFF.
Compared to an average industry Current Ratio of 2.12, IFF is worse placed to pay its short term obligations than its industry peers.

A Quick Ratio of 0.93 indicates that IFF may have some problems paying its short term obligations.
When comparing the Quick Ratio of IFF to the average industry Current Ratio of 1.33, IFF is less able to pay its short term obligations than its industry peers.
Based on the Altman-Z score of 1.60, we must say that IFF is in the distress zone and has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 2.73, IFF is in worse financial health than its industry peers.
VS Industry

Debt/Equity (0.61) VS Industry: 45% outperformed.

19.13
0.00

Quick Ratio (0.93) VS Industry: 24% outperformed.

0.01
65.94

Current Ratio (1.79) VS Industry: 39% outperformed.

0.01
65.94

Altman-Z (1.6) VS Industry: 23% outperformed.

-529.45
147.59

Dividend

Dividend Rating

4

Compared to an average industry Dividend Yield of 2.22, IFF pays a bit more dividend than its industry peers.
IFF has paid a dividend for at least 10 years, which is a reliable track record.
IFF has a Yearly Dividend Yield of 2.88%.
Compared to an average S&P500 Dividend Yield of 2.41, IFF has a dividend comparable with the average S&P500 company.

The dividend of IFF has a limited annual growth rate of 3.45%.
IFF's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
The earnings of IFF are negative and hence is the payout ratio. IFF will probably not be able to sustain this dividend level.
VS Industry

Dividend Yield (2.88%) VS Industry: 61% outperformed.

0.30
22.94

INTL FLAVORS & FRAGRANCES114.105

NYSE:IFF (2/2/2023, 8:36:08 AM)+0.59 (+0.52%)

Chartmill FA Rating
GICS Sector Materials
GICS IndustryGroup Materials
GICS Industry Chemicals
Earnings (Last) 11-07 2022-11-07/amc Earnings (Next) 02-07 2023-02-07
Inst Owners 87.12% Inst Owner Change 0.23%
Ins Owners 0.05% Ins Owner Change -1.93%
Market Cap 29.09B Analysts 74.62
Price Target 125.58 (10.06%)

Dividend
Dividend Yield 2.88% Dividend Growth 3.45%
DP -45.9% Ex-Date N/A

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 3.97%
Min EPS beat(2) 2.29% Max EPS beat(2) 5.66%
EPS beat(4) 4 Avg EPS beat(4) 9.19%
Min EPS beat(4) 2.29% Max EPS beat(4) 23.62%
Revenue beat(2) 1 Avg Revenue beat(2) -0.2%
Min Revenue beat(2) -1.38% Max Revenue beat(2) 0.98%
Revenue beat(4) 3 Avg Revenue beat(4) 1.2%
Min Revenue beat(4) -1.38% Max Revenue beat(4) 3.03%
PT rev (1m) 1.61% PT rev (3m) -9.19%
EPS NQ rev (1m) 0% EPS NQ rev (3m) -13.64%
EPS NY rev (1m) 0% EPS NY rev (3m) -0.9%
Revenue NQ rev (1m) 0% Revenue NQ rev (3m) -5.54%
Revenue NY rev (1m) 0% Revenue NY rev (3m) -1.55%

Valuation
Industry RankSector Rank
PE 20.05
Fwd PE 19.39
P/S 2.3
P/FCF 9697.45
P/OCF 58.18
P/B 1.72
P/tB N/A
EV/EBITDA 16.84
EPS(TTM) 5.69 EY 4.99%
EPS(NY) 5.88 Fwd EY 5.16%
FCF(TTM) 0.01 FCFY 0.01%
OCF(TTM) 1.96 OCFY 1.72%
SpS 49.53 BVpS 66.23
TBVpS -22.76 PEG (NY) N/A
PEG (5Y) 32.84

Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 2.92%
ROICexc 2.97%
ROICexgc 11.52%
OM 8.89%
PM N/A
GM 33.76%
ROICexgc(3y) 14.63% ROICexcg growth 3Y -30.89%
ROICexcg growth 5Y -28.31% ROICexc(3y) 3.61%
ROICexc growth 3Y -30.76% ROICexc growth 5Y -38.13%
OM growth 3Y -28.68% OM growth 5Y -20.93%
PM growth 3Y -35.03% PM growth 5Y -29.24%
GM growth 3Y -8.84% GM growth 5Y -6.48%
F-Score 4 Asset Turnover 0.37

Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 3592.67
Debt/EBITDA 4.66
Cap/Depr 41.69%
Profit Quality N/A
Current Ratio 1.79
Quick Ratio 0.93
Altman-Z 1.6
F-Score 4 WACC 8.92%
ROIC/WACC 1.29 Cap/Depr(3y) 56.05%
Cap/Depr(5y) 75.45% Profit Quality(3y) 211.3%
Profit Quality(5y) 160.39%

Growth
EPS 1Y -3.4% EPS 3Y -2.99%
EPS 5Y 0.61% EPS growth Q2Q -7.48%
EPS Next Y -0.52% EPS Next 2Y 1.87%
EPS Next 3Y 5.42% EPS Next 5Y 8.19%
Revenue growth 1Y 27.61% Revenue growth 3Y 43.1%
Revenue growth 5Y 30.19% Revenue growth Q2Q -0.26%
Revenue Next Year 7.72% Revenue Next 2Y 4.34%
Revenue Next 3Y 4.44% Revenue Next 5Y 4.79%
EBIT growth 1Y 101.51% EBIT growth 3Y 2.07%
EBIT growth 5Y 2.95% EBIT Next Year 33.35%
EBIT Next 3Y 14.72% EBIT Next 5Y 12.19%
FCF growth 1Y -99.44% FCF growth 3Y 57.89%
FCF growth 5Y 19.67% OCF growth 1Y -31.6%
OCF growth 3Y 48.64% OCF growth 5Y 21.17%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA